Cargando…

Tixagevimab-Cilgavimab Rollout on Common Variable Immunodeficient Patients: Early Lessons from an Academic Allergy and Immunology Clinic

Detalles Bibliográficos
Autores principales: Dluzynski, Daniela, Al-Shaikhly, Taha, Henao, Maria Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Mosby, Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895889/
http://dx.doi.org/10.1016/j.jaci.2022.12.085
_version_ 1784881943533322240
author Dluzynski, Daniela
Al-Shaikhly, Taha
Henao, Maria Paula
author_facet Dluzynski, Daniela
Al-Shaikhly, Taha
Henao, Maria Paula
author_sort Dluzynski, Daniela
collection PubMed
description
format Online
Article
Text
id pubmed-9895889
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Published by Mosby, Inc.
record_format MEDLINE/PubMed
spelling pubmed-98958892023-02-06 Tixagevimab-Cilgavimab Rollout on Common Variable Immunodeficient Patients: Early Lessons from an Academic Allergy and Immunology Clinic Dluzynski, Daniela Al-Shaikhly, Taha Henao, Maria Paula J Allergy Clin Immunol Article Published by Mosby, Inc. 2023-02 2023-02-03 /pmc/articles/PMC9895889/ http://dx.doi.org/10.1016/j.jaci.2022.12.085 Text en Copyright © 2022 Published by Mosby, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Dluzynski, Daniela
Al-Shaikhly, Taha
Henao, Maria Paula
Tixagevimab-Cilgavimab Rollout on Common Variable Immunodeficient Patients: Early Lessons from an Academic Allergy and Immunology Clinic
title Tixagevimab-Cilgavimab Rollout on Common Variable Immunodeficient Patients: Early Lessons from an Academic Allergy and Immunology Clinic
title_full Tixagevimab-Cilgavimab Rollout on Common Variable Immunodeficient Patients: Early Lessons from an Academic Allergy and Immunology Clinic
title_fullStr Tixagevimab-Cilgavimab Rollout on Common Variable Immunodeficient Patients: Early Lessons from an Academic Allergy and Immunology Clinic
title_full_unstemmed Tixagevimab-Cilgavimab Rollout on Common Variable Immunodeficient Patients: Early Lessons from an Academic Allergy and Immunology Clinic
title_short Tixagevimab-Cilgavimab Rollout on Common Variable Immunodeficient Patients: Early Lessons from an Academic Allergy and Immunology Clinic
title_sort tixagevimab-cilgavimab rollout on common variable immunodeficient patients: early lessons from an academic allergy and immunology clinic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895889/
http://dx.doi.org/10.1016/j.jaci.2022.12.085
work_keys_str_mv AT dluzynskidaniela tixagevimabcilgavimabrolloutoncommonvariableimmunodeficientpatientsearlylessonsfromanacademicallergyandimmunologyclinic
AT alshaikhlytaha tixagevimabcilgavimabrolloutoncommonvariableimmunodeficientpatientsearlylessonsfromanacademicallergyandimmunologyclinic
AT henaomariapaula tixagevimabcilgavimabrolloutoncommonvariableimmunodeficientpatientsearlylessonsfromanacademicallergyandimmunologyclinic